Median Diagnostics Inc. (XKON:233250)

South Korea · Delayed Price · Currency is KRW

4,800.00

-200.00 (-4.00%)

At close: Sep 11, 2026

Market Cap	8.38B -60.0%
Revenue (ttm)	7.86B +40.4%
Net Income	-567.58M
EPS	-496.00
Shares Out	1.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	5,000.00
Day's Range	n/a
52-Week Range	4,505.00 - 13,760.00
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Median Diagnostics

Median Diagnostics Inc. manufactures and sells veterinary medicines and diagnostic reagents. The company’s products include PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; ELISA for pigs, ruminants, avians, and horses; standard reagents, including AGID, HI, and FA; and antigen/antibody, including antibodies for veterinary diagnostics, and antibodies and antigens for human diagnostics. It also offers mouse and rat path... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances

Founded 1999

Country South Korea

Stock Exchange Korea New Exchange

Ticker Symbol 233250

Full Company Profile